Clinical Trials and Research

The Center for Research on Women’s Health and Reproductive Medicine is currently conducting the following clinical research studies in reproductive medicine:

Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone (Endometrin^®) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)

The purpose of this research study is to learn if a new formulation of subcutaneous injectable progesterone (Progesterone-IBSA) is as effective as a recently FDA approved vaginal preparation (Endometrin®) in helping to maintain pregnancy in an IVF cycle. If you are between the ages of 18 and 42, of healthy weight, in general good health, have had less than 3 prior IVF cycles, and not currently undergoing PGD, then you may be eligible for this study. Progesterone medication and $1500 which could be used to help defray the cost of the IVF cycle will be provided. See details. Please contact Tasha Kalista for additional information.

Tasha Kalista
Clinical Research Coordinator
tkalista@stanford.edu
650-725-9977
 

A Study of the Effect of Healing Touch therapy or Mind-Body Counseling on stress in women undergoing IVF

The purpose of this research study is to examine the effect of healing touch therapy to reduce stress in women currently undergoing IVF. If you are under the age of 41, have not had IVF treatment in the past, have no diagnosis of diminished ovarian reserve, and not currently seeking other energy work (reiki, acupuncture, massage, etc.) then you may be eligible for this study. Women will be randomized to one of three treatment groups: either 4 healing touch sessions, or 4 mind-body counseling group sessions or no intervention (control group). See details. Please contact Margaret Reynolds-May for additional information.

Margaret Reynolds-May
Clinical Research Coordinator
margaret.reynolds@stanford.edu
650-498-7625
 

Efficacy of Semi-Quantitative Urine Pregnancy Test

The purpose of this research study is to examine the relationship between an FDA-approved semi-quantitative urine pregnancy test and pregnancy serum (blood) levels in patients undergoing IVF. If you are currently undergoing an IVF Cycle at the Stanford Fertility and Reproductive Medicine Center and you are willing to take a urine pregnancy test twice on the same day as your pregnancy serum (blood) test, then you may be eligible for this study. Patients will receive a $30 Target gift card for participating in this study. Please contact Kelsy Lynd for additional information.

Kelsey Lynd
Clinical Research Coordinator
klynd@stanford.edu
650-721-1237